Concepts at the intersection of the nervous and immune systems -- where neuroinflammation, sickness behaviour, microglial activation, and brain-immune crosstalk live. In cPNI, this axis explains how psychological states alter immune function and how immune activation drives fatigue, depression, and cognitive dysfunction.
| Concept | Categories |
|---|---|
| 2-AG | molecule-mediator |
| 3-Hydroxykynurenine | process |
| 5-HT | molecule-mediator |
| A-delta fibres | uncategorized |
| A1 beta-casein | process |
| ACEs | psychological |
| Acetylcholine | molecule-mediator |
| ADHD | process |
| Adrenaline | molecule-mediator, cell-type |
| adverse childhood experiences | process, psychological |
| AGEs | process |
| Akt | system-axis, gene-protein |
| ALLO | process |
| Allostatic load | diagnostic |
| Alzheimer's Disease | clinical-concept |
| AMPs | -- |
| anandamide | molecule-mediator |
| Ang 1-7 | molecule-mediator |
| anger | psychological |
| angiotensin 1-7 | molecule-mediator |
| anhedonia | process |
| anorexia | process |
| anorexia nervosa | clinical-concept, intervention, psychological |
| anosmia | process |
| anterior cingulate cortex | structure, psychological, process |
| anterior insula | psychological |
| antioxidant defense | nutrient |
| arachidonic acid | molecule-mediator |
| arachidonic acid | molecule-mediator |
| ARDS | clinical-concept |
| area postrema | structure |
| Ashwagandha | uncategorized |
| asthma | clinical-concept |
| astrocyte | molecule-mediator, cell-type |
| astrocytes | molecule-mediator, cell-type |
| ataxia | -- |
| Autism | clinical-concept |
| autoimmune conditions | clinical-concept |
| autoimmune disease | clinical-concept |
| autoimmune diseases | clinical-concept, process |
| Autoimmunity | clinical-concept |
| autonomic balance | structure |
| Autonomic nervous system | structure, system-axis, psychological |
| autonomic regulation | psychological, process |
| autophagy | intervention, nutrient |
| axon | receptor-channel, molecule-mediator |
| B cells | cell-type |
| B vitamins | nutrient |
| B-complex | molecule-mediator |
| B-vitamins | molecule-mediator |
| B12 | molecule-mediator |
| B7-2 | receptor-channel |
| BALT | structure |
| barracks-boulevards-battlefields model | framework |
| barrier dysfunction | process, cell-type, clinical-concept |
| basal ganglia | psychological |
| basolateral amygdala | psychological |
| beta-casein | clinical-concept, process |
| beta-endorphins | molecule-mediator |
| betaine | nutrient, molecule-mediator |
| Bifidobacterium infantis | organism |
| Biological amplification | process, intervention |
| Biophotonic signalling | intervention, historical |
| blood-brain barrier | structure, intervention, nutrient |
| bonding system physiology and cognitive reserve | -- |
| Bradykinin | process |
| brain | structure |
| brain fog | psychological, process |
| brain function | psychological, molecule-mediator, process |
| brain-immune axis | system-axis, structure, intervention |
| Brainstem | uncategorized |
| breathwork | intervention |
| Butyrate | molecule-mediator, process, intervention |
| Butyrophilin | clinical-concept |
| C tactile fibres | psychological |
| c-Fos | gene-protein |
| c-Fos labeling | structure, intervention |
| C1q | cell-type |
| caloric restriction | process |
| CAMP | framework |
| CB1 | receptor-channel |
| CB1 receptor | receptor-channel, molecule-mediator |
| CB2 receptors | receptor-channel, process |
| CD4+ T cells | cell-type |
| cell membrane | system-axis, molecule-mediator |
| cell membranes | system-axis, intervention |
| central sensitisation | process |
| central-sensitisation | process |
| CGRP | molecule-mediator, process |
| cholinergic anti-inflammatory pathway | system-axis |
| chronic fatigue syndrome | clinical-concept, process |
| chronic inflammation | process, clinical-concept |
| Chronic Life Stress | process |
| chronic pain | process |
| chronic pain syndromes | clinical-concept, process |
| chronic-fatigue | molecule-mediator |
| chronic-fatigue-syndrome | clinical-concept |
| chronic-inflammation | process, clinical-concept |
| circadian disruption | clinical-concept, environmental, process |
| Circumventricular organs | structure |
| Clinical PNI | framework |
| Clonidine | molecule-mediator |
| cognitive conscience | diagnostic, psychological |
| cognitive decline | process, psychological |
| cognitive distortions | framework |
| cognitive dysfunction | process |
| cognitive function | psychological, process |
| Cognitive Immune System | psychological, system-axis |
| cognitive impairment | structure, nutrient, psychological |
| Cognitive Reserve | psychological, structure |
| Coherence Disturbance | uncategorized |
| cold exposure | process, intervention |
| cold-exposure | intervention, process |
| Collagen receptor signaling | cell-type, system-axis, intervention |
| conditioned immune response | psychological |
| Conditioned immunomodulation | psychological |
| conditioned immunosuppression | psychological |
| Conserved Transcriptional Response to Adversity | gene-protein, process |
| corpus callosum degeneration | clinical-concept, process |
| cortex insularis | psychological |
| Cortisol | molecule-mediator |
| cortisol resistant | molecule-mediator, process |
| COVID-19 | receptor-channel, intervention, psychological |
| COVID-19 anosmia | nutrient, environmental |
| COX2 | molecule-mediator, process |
| CpG | process, gene-protein, environmental |
| CpG islands | process, gene-protein |
| CREB | process |
| CRF | molecule-mediator |
| CRH | molecule-mediator |
| CRP as depression biomarker | process, diagnostic |
| CTRA | gene-protein, process |
| cytokine | process, gene-protein |
| Cytokine receptors | receptor-channel, system-axis |
| Cytokine resistance | intervention |
| cytokine signaling | process |
| Cytokine storm | clinical-concept |
| Cytokines | process |
| dACC | psychological, structure, process |
| David Felten | historical |
| delta opioid receptor | receptor-channel |
| dementia | process |
| Depression | clinical-concept, process |
| depression chronic pain chronic fatigue — bonding system failure | -- |
| descending facilitation | process, molecule-mediator |
| descending pain modulation | process, psychological, intervention |
| Design limits | structure, intervention, historical |
| despair | psychological |
| developmental programming | process |
| DHA | molecule-mediator |
| Diagnostics | diagnostic |
| diet-induced neuropathy | molecule-mediator, process |
| Digital-AMP | -- |
| DIMs | psychological, intervention |
| discrimination | process |
| disgust | psychological |
| disgust response | psychological, cell-type |
| disgust sensitivity | psychological |
| DNA | gene-protein |
| DNA damage | process, nutrient, environmental |
| DNA methyltransferases | molecule-mediator, process, gene-protein |
| Docosahexaenoic Acid | molecule-mediator |
| dolor | process |
| dorsal anterior cingulate cortex | structure |
| dorsal motor nucleus of vagus | structure |
| dorsal root ganglia | structure |
| DREADD | uncategorized |
| dura mater | structure |
| dural sinuses | structure |
| dural sinuses | structure |
| EAMP | psychological |
| efferent neural pathways | molecule-mediator, cell-type, structure |
| EGCG | molecule-mediator, nutrient |
| egodystonic | psychological |
| eicosanoid | molecule-mediator, process |
| Eicosapentaenoic Acid | molecule-mediator |
| electronic pollution and brainwave interference | -- |
| emotional | diagnostic, psychological |
| Emotional AMP | diagnostic, psychological |
| Endocannabinoid System | system-axis, molecule-mediator, cell-type |
| Endoplasmic Reticulum Stress | nutrient |
| Endorphin | molecule-mediator |
| endorphin resistance | process, clinical-concept, intervention |
| Endorphins | molecule-mediator |
| endothelial dysfunction | process |
| Energy Distribution | process, psychological |
| energy metabolism | cell-type, nutrient |
| Enkephalin | molecule-mediator |
| enkephalins | molecule-mediator |
| eNOS | molecule-mediator, intervention |
| enteroviruses | organism, clinical-concept |
| environmental stressor | environmental, structure, gene-protein |
| environmental toxins | process, environmental |
| EPA | molecule-mediator |
| Epicatechins | nutrient, molecule-mediator |
| epigenetic | gene-protein |
| Epigenetic Modifications | process |
| epigenetics | organism |
| Epinephrine | molecule-mediator, receptor-channel, cell-type |
| EPO | molecule-mediator |
| ERK | process, gene-protein |
| ERK1-2 | process, gene-protein |
| estradiol | molecule-mediator |
| estrogen | molecule-mediator |
| estrogen receptors | gene-protein, receptor-channel |
| estrogens | molecule-mediator |
| ETL | clinical-concept, gene-protein |
| evolutionary biology | framework |
| Evolutionary constraints | framework |
| Evolutionary Scars | intervention, historical |
| evolutionary theory of loneliness | process |
| excitotoxicity | molecule-mediator |
| Exocannabinoids | intervention, molecule-mediator |
| Expression Suppression Syndrome | process, clinical-concept |
| family constellations | psychological, clinical-practice |
| fatigue | molecule-mediator, cell-type, structure |
| fear | psychological |
| Fibromyalgia | molecule-mediator, clinical-concept, psychological |
| Fibromyalgia | psychological, molecule-mediator, clinical-concept |
| folate | molecule-mediator |
| FoxO1 | gene-protein |
| FPR1 | receptor-channel, process |
| free radicals | system-axis |
| frontotemporal dementia | clinical-concept, intervention, psychological |
| Frozen shoulder | clinical-concept |
| G-Protein Receptor | receptor-channel, system-axis |
| GABA | molecule-mediator |
| GAD-antibody spectrum disorders | clinical-concept |
| GAD65 | molecule-mediator |
| GAD67 | molecule-mediator |
| gene expression | process |
| gene-environment interaction | process |
| Gliadin | process, clinical-concept |
| Glial Cells | cell-type |
| Gliederschmerzen | process |
| Glucocorticoid Receptor | receptor-channel, gene-protein |
| Glucose | cell-type, structure, psychological |
| gluten sensitivity | process, clinical-concept |
| glycolipids | molecule-mediator, cell-type, system-axis |
| glycoproteins | uncategorized |
| GMP-7 | receptor-channel, psychological |
| GPR35 | receptor-channel, organism |
| GSH | molecule-mediator |
| gut | structure |
| health anxiety | psychological |
| heart | structure |
| heart failure | clinical-concept, process |
| heart rate variability | diagnostic |
| heat exposure | intervention, process |
| heat shock protein | process |
| Heat shock proteins | process |
| heat stress | process |
| heavy metals | environmental |
| Helicopter parenting | psychological, clinical-concept, intervention |
| Hemispheric lateralization of immunity | uncategorized |
| HIF | gene-protein, process |
| HIF-1 | process, gene-protein |
| Hippocampus | structure |
| Histamine | process |
| HITM-AMP | -- |
| HIV | organism |
| HMGB1 | process, molecule-mediator |
| Homeostasis | system-axis |
| Hormones | system-axis |
| HRV | diagnostic |
| HSR | uncategorized |
| Humanin | intervention, receptor-channel, system-axis |
| Hydroxytyrosol | molecule-mediator, nutrient |
| hyperalgesia | receptor-channel, intervention |
| Hypercortisolaemia | clinical-concept |
| Hypothalamic Inflammation | process, cell-type, intervention |
| hypothalamic neuroinflammation | process, clinical-concept |
| hypothalamic-inflammation | process |
| Hypothalamus | structure |
| Hypothalamus inflammation | process, cell-type, structure |
| hypoxia | psychological, gene-protein |
| Hypoxia stress response | gene-protein |
| Hypoxia-Inducible Factor | gene-protein |
| IBS | clinical-concept, process |
| Identity-Oriented Psychotrauma Therapy | psychological, clinical-practice |
| IDO | molecule-mediator |
| IFN-alpha | molecule-mediator, process |
| IFN-γ | molecule-mediator, process |
| IL-1 | molecule-mediator |
| IL-1 receptor | molecule-mediator, receptor-channel |
| IL-12 | molecule-mediator |
| IL-1β | molecule-mediator |
| IL-4 | molecule-mediator |
| IL-6 | molecule-mediator, process |
| IML | structure |
| immune activation | process, psychological |
| immune cell | cell-type |
| immune cell trafficking | cell-type |
| immune cells | cell-type |
| immune conditioning | psychological |
| Immune Homunculus | structure |
| immune responses | nutrient |
| immune suppression | uncategorized |
| immune system | system-axis |
| Immune system in the brain | cell-type, molecule-mediator |
| Immune transmitters | system-axis |
| immune-to-brain signaling | psychological |
| Immunengram | cell-type |
| Immunoception | psychological, process |
| immunoceptivity | psychological |
| immunological set points | environmental |
| imprinting-bonding safety and security | -- |
| indoleamine 2,3-dioxygenase | molecule-mediator |
| inflammaging | clinical-concept, intervention |
| inflammation | process, cell-type, clinical-concept |
| inflammatory | process |
| inflammatory conditions | clinical-concept, process |
| inflammatory cytokines | molecule-mediator, system-axis, process |
| Inflammatory pain | process |
| inflammatory reflex | diagnostic |
| inflammatory response | process |
| inflammatory signals | system-axis |
| infrared therapy | intervention |
| innate lymphoid cells | cell-type |
| insula | structure, psychological |
| insular cortex | structure, psychological |
| insular-cortex | structure, psychological |
| interferon-alpha | molecule-mediator, intervention |
| Interferon-gamma | molecule-mediator |
| Interleukin-1 | molecule-mediator |
| Interleukin-4 | molecule-mediator |
| Interleukin-6 | molecule-mediator, process |
| Intermittent fasting | process, intervention |
| Internal Milieu | system-axis, nutrient, psychological |
| interoception | process, diagnostic |
| Interoceptive signals | system-axis |
| introns | gene-protein, process |
| iron | nutrient |
| JNK | process |
| kappa opioid receptor | receptor-channel, molecule-mediator |
| KAT | molecule-mediator |
| ketogenic diet | process, nutrient |
| KOR | receptor-channel |
| KYNA | molecule-mediator |
| Kynurenic acid | molecule-mediator |
| Lactobacillus rhamnosus | uncategorized |
| Leukemia inhibiting factor | molecule-mediator |
| leukocyte redistribution | cell-type, process |
| LGI | clinical-concept, nutrient, environmental |
| Loneliness | process |
| Long COVID | intervention, psychological |
| Long-COVID | process |
| Luteolin | nutrient, molecule-mediator |
| lymph nodes | cell-type |
| lymphoid organs | cell-type |
| lysophospholipids | molecule-mediator, process |
| mast cell | cell-type |
| Mast Cell Degranulation | cell-type, process, intervention |
| Mast cells | cell-type, process |
| mechanisms of action | framework, process |
| medial prefrontal cortex | psychological, structure |
| Medial Thalamus | psychological, structure |
| Meditation | process, intervention |
| Medulla | structure |
| Melatonin | molecule-mediator |
| Meningeal immune cells | cell-type |
| Meningeal immune cells | cell-type |
| meninges | structure |
| Menopause | process |
| menstrual cycle | clinical-concept |
| mental health | process |
| Merkel cells | cell-type |
| metabolic switching | cell-type |
| metabolic-dysfunction | clinical-concept, process, psychological |
| Methylation | process |
| Microglia | cell-type |
| microglial activation | process |
| microgliosis | clinical-concept, process |
| micronutrient deficiencies | clinical-concept |
| microRNA | process |
| Migraine | clinical-concept, intervention |
| mirror pain | process |
| mitochondria | structure |
| Mitochondrial Information Processing System | system-axis, intervention, framework |
| mitohormesis | process |
| Mitophagy | process, intervention |
| mitoresilience | intervention, psychological |
| MOG | organism |
| mood disorders | molecule-mediator, clinical-concept |
| Morphine | molecule-mediator |
| MSH | molecule-mediator, process |
| mtDNA | gene-protein |
| MTHFR | molecule-mediator, gene-protein |
| mu opioid receptor | receptor-channel, molecule-mediator |
| Multiple Sclerosis | clinical-concept, process |
| myasthenia gravis | clinical-concept |
| mycotoxins | molecule-mediator, organism, historical |
| Myelin Based Protein | uncategorized |
| Myelin Oligodendrocyte Glycoprotein | intervention |
| naked mole rat | uncategorized |
| NALT | cell-type, structure, psychological |
| NATAF hypothesis | framework, clinical-concept |
| nerve growth factor | process |
| Netrin-1 | process |
| Neu5Ac | molecule-mediator, cell-type, intervention |
| neuro-endocrino-immune interface | molecule-mediator, cell-type, system-axis |
| neuro-immune synapses | molecule-mediator, cell-type, structure |
| neurodegeneration | clinical-concept, process |
| Neuroimmune cell units | cell-type, receptor-channel |
| neuroimmunological synapses | molecule-mediator, cell-type, structure |
| neuroinflammation | process, cell-type, psychological |
| neuroneogenesis | process |
| neuropathic pain | receptor-channel, clinical-concept, diagnostic |
| neuropathic pain pharmacotherapy | intervention, receptor-channel |
| Neuropeptide | molecule-mediator |
| Neuropeptides | molecule-mediator |
| Neuroprotectins | molecule-mediator |
| Neuroprotectins | molecule-mediator, process |
| neurotransmitter synthesis | process, nutrient, psychological |
| NF-kB | gene-protein, process |
| NGF | receptor-channel |
| NGFBP-1 | receptor-channel, intervention |
| niacin | molecule-mediator |
| Nicholas Cohen | intervention, psychological |
| Nicotinamide | molecule-mediator |
| nicotine | molecule-mediator |
| NICUs | cell-type, molecule-mediator, structure |
| Nitric Oxide | process |
| NK cell | cell-type |
| NK cells | cell-type |
| NMDA receptor | receptor-channel |
| norepinephrine | molecule-mediator |
| Nuclei Raphei | uncategorized |
| nucleus accumbens | psychological |
| nucleus raphe | psychological |
| Nucleus tractus solitarius | structure |
| nutrient deficiencies | nutrient, psychological |
| nutrients | nutrient |
| obsessive-compulsive disorder | clinical-concept |
| OCD | clinical-concept, psychological |
| Oestradiol | psychological, diagnostic |
| oestrogen | psychological |
| olfactory bulb | structure, environmental, diagnostic |
| olfactory dysfunction | diagnostic, process |
| olfactory epithelium | structure |
| olfactory system | system-axis |
| Omega-3 fatty acids | molecule-mediator |
| Opioid tolerance | uncategorized |
| Optimism | psychological |
| overtraining syndrome | process, clinical-concept |
| oxidative damage | process |
| P2X3 Receptor | receptor-channel |
| PAR-2 | receptor-channel, structure, process |
| parabrachial nucleus | psychological, structure |
| Parasympathetic | molecule-mediator |
| parasympathetic nervous system | molecule-mediator, system-axis |
| paraventricular nucleus | structure, psychological |
| Parkinson's Disease | process, clinical-concept, molecule-mediator |
| pattern recognition receptors | cell-type |
| Peptidyl Arginine Deiminase 4 | clinical-concept |
| periaqueductal gray | structure, psychological |
| peripheral sensitization | process |
| peroxynitrite | process |
| persistent pain | process |
| PGE2 | molecule-mediator, process |
| Pharmacological Conditioning | psychological |
| PHD Inhibitors | intervention |
| phospholipase A2 | molecule-mediator, process |
| photobiomodulation | intervention, process |
| photographic medicine | -- |
| photoperiod | environmental |
| physical activity | intervention, process |
| pia mater | structure |
| PKA | molecule-mediator, system-axis, receptor-channel |
| PKC | molecule-mediator, system-axis, receptor-channel |
| PLA2G7 | molecule-mediator |
| PLA2G7 | molecule-mediator |
| pollution | environmental, process |
| Porphyromonas gingivalis | organism |
| Post-translational modification | process |
| posterior insula | psychological, structure |
| postpartum depression | process |
| Prefrontal cortex | structure |
| proglumide | intervention |
| pronociceptive metabolites | molecule-mediator, process |
| Protectins | molecule-mediator |
| protein folding | process, environmental |
| Psoriasis | clinical-concept |
| Psychobiotics | molecule-mediator, intervention, psychological |
| psychological stress | process, clinical-concept |
| psychoneuroimmune | molecule-mediator, cell-type, structure |
| Psychoneuroimmunology | molecule-mediator, cell-type, framework |
| psychosocial stress | process, clinical-concept |
| Purpose in Life | psychological, clinical-practice |
| quinolinic acid | molecule-mediator, intervention, psychological |
| Reactive Oxygen Species | system-axis |
| resilience | process |
| resveratrol | intervention, nutrient, molecule-mediator |
| reward system | psychological, system-axis |
| Robert Ader | historical, psychological |
| Rostral ventrolateral medulla | structure |
| RvD1 | molecule-mediator |
| RVLM | structure |
| Saffron | molecule-mediator, psychological |
| Sage | molecule-mediator |
| saliva | structure |
| salutary relationships | clinical-concept, diagnostic, gene-protein |
| SAMP | process |
| SARS-CoV-2 | organism |
| sauna | process, intervention, environmental |
| Schizophrenia | clinical-concept |
| self-protective coping | clinical-concept |
| selfish-immune-system | process, system-axis |
| sensitisation | process |
| Senso-Immunology | receptor-channel, cell-type |
| sensoimmunology | cell-type, clinical-concept, intervention |
| SHLP1-6 | system-axis, intervention |
| SHMT2 | molecule-mediator |
| SHP-1 | intervention |
| sialic acid | cell-type, nutrient |
| Sialic Acid Binding Immune Globulin Like Lectin | receptor-channel |
| Sialic acid-binding Ig-like lectins | receptor-channel |
| sialylation | process, intervention |
| sickness behaviour | process |
| sight | environmental |
| Siglecs | cell-type, intervention |
| SIMs | intervention, diagnostic, psychological |
| singing | intervention |
| single nucleotide polymorphisms | gene-protein |
| Sinomenine | receptor-channel, structure, intervention |
| Sjögren's syndrome | clinical-concept |
| skin | structure |
| skin-to-skin contact | intervention |
| SLC6A4 | uncategorized |
| sleep | process, psychological |
| sleep deprivation | process |
| sleep disorders | process, clinical-concept |
| sleep optimization | process, intervention |
| sleep quality | diagnostic |
| small fiber neuropathy | clinical-concept, receptor-channel |
| smell | process |
| smoking | process, clinical-concept |
| social isolation | process |
| social withdrawal | process |
| stiff body disease | clinical-concept, molecule-mediator |
| Stiff person syndrome | clinical-concept |
| stress axes | diagnostic |
| Stress Axis Desynchronization | process |
| Stress Axis Desynchronization | clinical-concept, process |
| stress pheromones | psychological |
| stress physiology | molecule-mediator, cell-type, psychological |
| stress reduction | intervention, process |
| stress resilience | process, psychological |
| stress response | cell-type, psychological |
| stress responses | psychological |
| Stress-induced immunoenhancement | cell-type, psychological |
| stroke | clinical-concept |
| subarachnoid space | structure |
| Substance P | molecule-mediator, process |
| Survival Self | psychological, clinical-practice |
| sympathetic | cell-type, clinical-concept |
| sympathetic dominance | clinical-concept |
| sympathetic nervous system | system-axis, cell-type, clinical-concept |
| sympathetic tone | diagnostic |
| synaptic pruning | process |
| synaptic-plasticity | psychological, process |
| synaptogenesis | process, molecule-mediator, intervention |
| systemic inflammation | process, clinical-concept, diagnostic |
| Tai Chi Chih | intervention |
| TDO | molecule-mediator |
| telomere shortening | diagnostic |
| Text-Context Model | framework |
| Therapeutic hypercapnia | intervention, process |
| thermoregulation | process, psychological |
| threat detection | process |
| threat perception | psychological, process |
| threat sensitivity | process, psychological |
| time-restricted eating | intervention |
| TNF | molecule-mediator, process |
| TNF-α | molecule-mediator, process |
| Top-Down Control | psychological, intervention |
| transcription factor | gene-protein, process |
| Transferrins | process, nutrient |
| transgenerational epigenetic inheritance | process |
| Transketolase | molecule-mediator |
| TRAP mice | uncategorized |
| trauma | process |
| treatment-resistant depression | process, clinical-concept |
| Treg cells | cell-type, clinical-concept |
| Trigeminal nerve | structure |
| TrkA Receptor | receptor-channel |
| TRP channels | receptor-channel, cell-type, intervention |
| TRPA1 | receptor-channel |
| TRPV1 | receptor-channel |
| Tryptophan | molecule-mediator, organism |
| TSH receptor | receptor-channel, clinical-concept |
| TSHβ | molecule-mediator, cell-type |
| TSHβ variant | molecule-mediator |
| TSLP | molecule-mediator |
| tumor necrosis factor | molecule-mediator |
| Type II glucocorticoid receptor | receptor-channel, process |
| Vagus nerve | structure, intervention, diagnostic |
| vagus nerve stimulation | intervention, molecule-mediator |
| vasoconstriction | process, receptor-channel, nutrient |
| vasodilation | process |
| VCAM-1 | process, cell-type |
| VDR | gene-protein, receptor-channel, process |
| Vesicular communication | process, molecule-mediator, cell-type |
| visceral insular cortex | psychological, structure |
| White Matter Integrity | structure, psychological |
| ZO-1 | intervention |
| β-hydroxybutyrate | molecule-mediator, intervention |
| β2-adrenergic receptor | receptor-channel |